HCPCS J-code
J2779: ranibizumab biosimilar
Ranibizumab biosimilar 0.1 mg
Code
J2779
Generic
ranibizumab biosimilar
Brands
Cimerli, Byooviz
Drug class
Biologic drugs (mAbs and biosimilars)
Common denial patterns
- Originator preferred by some plans
Frequently asked questions
What is HCPCS J2779?
Ranibizumab biosimilar 0.1 mg
Why does insurance commonly deny J2779?
Originator preferred by some plans.
What brand-name drug uses J2779?
Cimerli, Byooviz.
Related
Appeal a J2779 denial
Upload the denial — we draft the appeal letter in 5 minutes citing the right clinical guideline.
Get started →Contact: hello@approvalhelp.com